title: Tuberculosis: old lessons unlearnt?
authors.forename: B
authors.initials: B
authors.lastname: Bloom
authors.forename: S
authors.initials: S
authors.lastname: Cole
authors.forename: K
authors.initials: K
authors.lastname: Duncan
authors.forename: D
authors.initials: D
authors.lastname: Enarson
authors.forename: P
authors.initials: P
authors.lastname: Fine
authors.forename: A
authors.initials: A
authors.lastname: Ginsberg
authors.forename: J
authors.initials: J
authors.lastname: La Montagne
authors.forename: P
authors.initials: P
authors.lastname: Smith
authors.forename: D
authors.initials: D
authors.lastname: Young
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D016903:Drug Monitoring; D014943:Global Health; D006292:Health Priorities; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D010349:Patient Compliance; D012106:Research; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents; D004338:Drug Combinations; D007538:Isoniazid; D012293:Rifampin